|
ES2470340T3
(es)
|
2005-12-28 |
2014-06-23 |
Advanced Bionutrition Corporation |
Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2008076975A1
(en)
|
2006-12-18 |
2008-06-26 |
Advanced Bionutrition Corporation |
A dry food product containing live probiotic
|
|
JP2012503637A
(ja)
|
2008-09-24 |
2012-02-09 |
スタビリテック リミテッド |
糖およびポリエチレンイミンを使用するポリペプチドの保存方法
|
|
EP3266448B1
(en)
|
2009-03-27 |
2022-02-16 |
Intervet International B.V. |
Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
|
|
JP5804453B2
(ja)
*
|
2009-05-14 |
2015-11-04 |
国立大学法人 東京大学 |
結晶性ポリオール微粒子及びその調製方法
|
|
AU2010254235B2
(en)
|
2009-05-26 |
2015-04-02 |
Advanced Bionutrition Corporation |
Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
BR112012018839B1
(pt)
*
|
2010-01-28 |
2020-04-14 |
Advanced Bionutrition Corp |
composição vítrea seca compreendendo um material bioativo
|
|
GB201002419D0
(en)
*
|
2010-02-12 |
2010-03-31 |
Isis Innovation |
Stable live vaccine formulations
|
|
JP5960120B2
(ja)
*
|
2010-03-31 |
2016-08-02 |
スタビリテック リミテッド |
ウイルス粒子の安定化
|
|
JP5869553B2
(ja)
|
2010-03-31 |
2016-02-24 |
スタビリテック リミテッド |
ウイルス粒子、ポリペプチド又は生体材料を安定化させる添加剤
|
|
GB2499480A
(en)
|
2010-03-31 |
2013-08-21 |
Stabilitech Ltd |
Method for preserving alum adjuvants and alum-adjuvanted vaccines
|
|
MX350047B
(es)
|
2010-08-13 |
2017-08-24 |
Advanced Bionutrition Corp |
Composicion de estabilizacion de almacenamiento en seco para materiales biologicos.
|
|
WO2012075379A2
(en)
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
|
CN103269716B
(zh)
|
2010-12-02 |
2015-05-27 |
昂科利蒂克斯生物科技公司 |
冻干病毒制剂
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
TWI690322B
(zh)
|
2012-10-02 |
2020-04-11 |
法商傳斯堅公司 |
含病毒的調配物及其使用
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
EP3552615B8
(en)
|
2014-07-16 |
2022-03-02 |
Transgene |
Oncolytic virus for expression of immune checkpoint modulators
|
|
ES3011733T3
(en)
|
2015-02-13 |
2025-04-08 |
Transgene |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
US12558395B2
(en)
|
2015-07-29 |
2026-02-24 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
EP3328215B1
(en)
|
2015-07-29 |
2021-07-07 |
Advanced BioNutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
WO2017035664A1
(en)
|
2015-09-02 |
2017-03-09 |
Mcmaster University |
Enhanced thermal stability for adenoviral vectors through spray drying
|
|
EP3452081A1
(en)
|
2016-05-04 |
2019-03-13 |
Transgene SA |
Combination therapy with cpg tlr9 ligand
|
|
TW201825674A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現雙特異性接合分子的溶瘤病毒
|
|
EP3522920A2
(en)
|
2016-10-10 |
2019-08-14 |
Transgene SA |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
US11626228B2
(en)
*
|
2016-12-22 |
2023-04-11 |
Rogers Corporation |
Multi-layer magneto-dielectric material
|
|
EP3562946B1
(en)
|
2016-12-28 |
2021-11-24 |
Transgene SA |
Oncolytic viruses and therapeutic molecules
|
|
US10617756B2
(en)
|
2017-01-05 |
2020-04-14 |
Shimojani, LLC |
Drug regimen for treatment of cerebral ischemia
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
JP7334124B2
(ja)
|
2017-06-21 |
2023-08-28 |
トランジェーヌ |
個別化ワクチン
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
WO2019170820A1
(en)
|
2018-03-07 |
2019-09-12 |
Transgene |
Parapoxvirus vectors
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
CN112739207A
(zh)
*
|
2018-09-28 |
2021-04-30 |
株式会社大塚制药工场 |
包含阿卡伯糖或水苏糖的哺乳动物细胞保存用液
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
WO2020136232A1
(en)
|
2018-12-28 |
2020-07-02 |
Transgene Sa |
Immunosuppressive m2 protein
|
|
CN113453712A
(zh)
|
2018-12-28 |
2021-09-28 |
特兰斯吉恩股份有限公司 |
M2缺陷型痘病毒
|
|
JP7810554B2
(ja)
|
2019-03-01 |
2026-02-03 |
アケロイス バイオファーマ， インコーポレイテッド |
抗原特異的免疫細胞におけるｃｄ１６０機能をモジュレートする方法およびその使用
|
|
US20230272368A1
(en)
*
|
2020-04-14 |
2023-08-31 |
Spectrum Solutions L.L.C. |
Products and methods for detection of viral nucleic acid
|
|
CN116322740A
(zh)
|
2020-07-13 |
2023-06-23 |
特兰斯吉恩股份有限公司 |
免疫抑制的治疗
|
|
JP2024504875A
(ja)
|
2021-02-01 |
2024-02-01 |
▲い▼尊生物医薬（浙江）有限公司 |
標的タンパク質分解システムおよびその応用
|
|
EP4340874A1
(en)
*
|
2021-05-21 |
2024-03-27 |
Takeda Vaccines, Inc. |
Solid composition, freeze-drying method and glass vial
|
|
CN113655057A
(zh)
*
|
2021-08-24 |
2021-11-16 |
威世药业（如皋）有限公司 |
一种检测冷冻干燥处理对痘苗病毒毒力影响的设备
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
CN114392237B
(zh)
*
|
2021-12-28 |
2024-02-02 |
上海允英生物医药科技有限公司 |
一种冻干病毒制剂及其制备方法
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
AU2023300419A1
(en)
|
2022-07-01 |
2025-01-02 |
Transgene |
Fusion protein comprising a surfactant-protein-d and a member of the tnfsf
|
|
WO2024038175A1
(en)
|
2022-08-18 |
2024-02-22 |
Transgene |
Chimeric poxviruses
|
|
WO2026041811A1
(en)
|
2024-08-23 |
2026-02-26 |
Transgene |
Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell
|